arrow
C

Carmine Carbone

San Raffaele Telethon Institute for Gene Therapy
H指数:34
被引数:3,731

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study

PD-L1 ≥ 50% 非小细胞肺癌中cemiplimab单药或联合短程化疗的超进展:一项生物标志物指导的多中心国际II期试验—HYPERBOLIC研究

2026-09-010
PRE
Injectable redox-responsive glutathione-polyurethane/hyaluronic acid hybrid hydrogel for controlled chemotherapy in patient-derived pancreatic cancer organoids

一种可注射的、基于谷胱甘肽-聚氨酯/透明质酸杂化水凝胶的氧化还原响应型水凝胶,用于在患者来源的胰腺癌类器官中实现可控化疗

2025-11-150
OAAI
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance

PI3K/mTORC2-RICTOR轴在早期鳞状非小细胞肺癌中的研究:基因组学、分子表达及其临床相关性

2025-11-070
OA
Local ablation disrupts immune evasion in pancreatic cancer
2025-01-010
OA
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance
2024-12-041
OAAI
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer

MAPK信号传导的差异活性定义了胰腺癌中的成纤维细胞亚型

2024-12-030
OAAI
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer

选择性剪接特征定义了基底样表型,并预测胰腺癌的临床预后较差

2024-02-017
OAAI
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer
2023-11-236
OAAI
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients

免疫检查点阻断疗法可减轻非进展期非小细胞肺癌患者的全身炎症并影响表达细胞FLIP的单核细胞髓源性抑制细胞

2023-09-145
OA
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer

CXCR1/2双重抑制剂ladarixin可减轻肿瘤负担并促进胰腺癌的免疫治疗反应

2022-11-1614
OA